Open access · CC-BY
via OpenAlex
Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World
Luis E. Fernández-Garza, Silvia A. Barrera‐Barrera, Hugo Alberto Barrera-Saldaña
Pharmaceuticals · 2023 · ▲ 87 citations
Abstract
Cellular therapy has used mesenchymal stem cells (MSCs), which in cell culture are multipotent progenitors capable of producing a variety of cells limited to the mesoderm layer. There are two types of MSC sources: (1) adult MSCs, which are obtained from bone marrow, adipose tissue, peripheral blood, and dental pulp; and (2) neonatal-tissue-derived MSCs, obtained from extra-embryonic tissues such as the placenta, amnion, and umbilical cord. Until April 2023, 1120 registered clinical trials had been using MSC therapies worldwide, but there are only 12 MSC therapies that have been approved by regulatory agencies for commercialization. Nine of the twelve MSC-approved products are from Asia, with Republic of Korea being the country with the most approved therapies. In the future, MSCs will play an important role in the treatment of many diseases. However, there are many issues to deal with before their application and usage in the medical field. Some strategies have been proposed to face these problems with the hope of reaching the objective of applying these MSC therapies at optimal therapeutic levels.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ph16091334
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Fernández-Garza, L.E., Barrera‐Barrera, S.A., & Barrera-Saldaña, H.A. (2023). Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World. <em>Pharmaceuticals</em>. https://doi.org/10.3390/ph16091334
Vancouver
Fernández-Garza LE, Barrera‐Barrera SA, Barrera-Saldaña HA. Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World. Pharmaceuticals. 2023. doi:10.3390/ph16091334.
BibTeX
@article{luis2023Mesenc,
title = {Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World},
author = {Luis E. Fernández-Garza and Silvia A. Barrera‐Barrera and Hugo Alberto Barrera-Saldaña},
journal = {Pharmaceuticals},
year = {2023},
doi = {10.3390/ph16091334},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Mechanisms of Ageing and Development 2007
Preprint · CC-BY
Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies
Stem Cells 2003
Citation only
Searching for Alternative Sources of Postnatal Human Mesenchymal Stem Cells: Candidate MSC‐Like Cells from Umbilical Cord
Cell & Bioscience 2020
Open access · CC-BY
Treatment of spinal cord injury with mesenchymal stem cells
International Journal of Molecular Sciences 2021
Open access · CC-BY
Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine
Bone 2014
Citation only
Characterization of bone marrow-derived mesenchymal stem cells in aging
International Journal of Molecular Sciences 2019
Open access · CC-BY